Product Name:4-(tert-Butoxycarbonyl)-4-azaspiro[2.5]octane-7-carboxylic acid
IUPAC Name:4-[(tert-butoxy)carbonyl]-4-azaspiro[2.5]octane-7-carboxylic acid
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM536739-100mg | in stock | Ůƿƿ |
|
| CM536739-250mg | in stock | ǙŮľ |
|
|
|||
| Product Overview |
4-(tert-Butoxycarbonyl)-4-azaspiro[2.5]octane-7-carboxylic acid is a chemical compound that has gained significant attention in the scientific community due to its potential applications in the field of medicine. This compound is also known as Boc-SPNO, and it belongs to the class of spirocyclic compounds. |
| Synthesis Method |
The synthesis of Boc-SPNO involves several steps, including the reaction of 1,5-dibromopentane with diethylamine to form 4-(diethylamino)butyl bromide. This intermediate is then reacted with sodium azide to form 4-azidobutylamine. The final step involves the reaction of 4-azidobutylamine with tert-butyl 2-oxocyclohexanecarboxylate to form Boc-SPNO. |
| Chemical Properties |
Boc-SPNO has been shown to have low toxicity, which is a desirable characteristic for any potential drug candidate. One of the main limitations is the complexity of its synthesis, which can make it difficult and time-consuming to produce in large quantities. |
| Synthesis and Application |
It has been shown to have antibacterial and antifungal properties, making it a promising candidate for the development of new antibiotics. Additionally, Boc-SPNO has been studied for its potential use in the treatment of cancer, as it has been shown to inhibit the growth of cancer cells in vitro. |
| Future Directions |
One area of interest is the development of new antibiotics based on the structure of Boc-SPNO. Researchers are also interested in studying the mechanism of action of Boc-SPNO in more detail, in order to better understand how it works and how it can be used to develop new drugs. Additionally, researchers are interested in exploring the potential use of Boc-SPNO in the treatment of cancer, as well as other diseases. |
Search 
+86 21 5895 0110 
